Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart

N C Edwards1, C J Ferro, J N Townend

  • 1Department of Cardiology, University of Birmingham and University Hospital Birmingham, Birmingham, UK.

Insights

Early-stage chronic kidney disease (CKD) leads to stiffer arteries and impaired heart function, increasing cardiovascular risk. This arterial-ventricular stiffness pattern resembles heart failure with preserved ejection fraction.

Area of Science:

  • Cardiovascular Physiology
  • Nephrology
  • Biomedical Engineering

Background:

  • Early-stage chronic kidney disease (CKD) is associated with increased cardiovascular risk.
  • Understanding arterial and ventricular function in early CKD is crucial for risk stratification and management.
  • This study investigates the interplay between arterial and left ventricular function in non-diabetic CKD patients.

Purpose of the Study:

  • To examine arterial and left ventricular function in patients with early-stage CKD.
  • To assess the interaction between arterial stiffness and ventricular elastance.
  • To compare cardiovascular parameters in early CKD patients with healthy controls.

Main Methods:

  • Cross-sectional observational study involving 117 patients with stage 2 or 3 non-diabetic CKD and 40 controls.
  • Cardiac magnetic resonance imaging (CMR) used to assess aortic distensibility and left ventricular mass.
  • Transthoracic echocardiography employed to evaluate systolic and diastolic ventricular function and arterial-ventricular elastance.

Main Results:

  • Patients with early CKD exhibited reduced aortic distensibility and increased arterial elastance compared to controls.
  • Left ventricular end-systolic and end-diastolic elastances were significantly increased in CKD patients.
  • While systolic function remained unimpaired, diastolic filling velocities were reduced, and mean left atrial pressure was elevated in early CKD.

Conclusions:

  • Early-stage CKD is characterized by arterial stiffening and increased ventricular stiffness.
  • The observed pattern of arterial and ventricular dysfunction resembles that seen in heart failure with preserved ejection fraction.
  • These pathophysiological changes may contribute to the high cardiovascular morbidity and mortality observed across all stages of CKD.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...